Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer

National Medical Journal of China

Volumn 87, Issue 3, 2007, Pages 155-160

  Zhang, Gui Hong ^a   Yang, Wen Tao ^b   Zhou, Xiao Yan ^b   Zeng, Yu ^b   Lu, Hong Fen ^b   Shi, Da Ren ^b  

^a FUDAN UNIVERSITY   (China)

^b NONE

Author keywords

Breast neoplasms; Endothelial growth factors; Genes; Lymphatic metastasis; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; TRASTUZUMAB; VASCULOTROPIN C; VASCULOTROPIN D;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; UPREGULATION;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; PROGNOSIS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33947189543     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Ross JS, Fletcher JA. HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol, 1999, 112: 53-67.
2. Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev, 2002, 82: 673-700.
3. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer, 2003, 98: 413-423.
4. Tsai PW, Shiah SG, Lin MT, et al. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem, 2003, 21, 278: 5750-5759.
5. Yang W, Klos K, Yang Y, et al. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C and D in human breast carcinoma. Cancer, 2002, 94: 2855-2861.
6. Shak S. Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. Semin Oncol, 1999, 26: 71-77.
7. Chinese source.
8. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2-Δ Δ Ct method. Methods, 2001, 25: 402-408.
9. Rsitimak A, Narko K, Enholm B, et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem, 1998, 273: 8413-8418.
10. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, as a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J, 1996, 15: 290-298.
11. Joukov V, Sorsa T, Kumar V, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J, 1997, 16: 3898-3911.
12. Schmid-Schonbein GW. Microlymphatics and lymph flow. Physiol Rev, 1990, 70: 987-1028.
13. Chinese source.